HRA model for hypercholesterolemia based on a longitudinal health database

Related Experiment Video

Updated: Oct 29, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

E Takahashi1, T Kishimoto, Y Iida

  • 1Dept of Preventive Medicine, St. Marianna University School of Medicine, Japan.

Methods of Information in Medicine
|July 10, 1998
PubMed

Insights

This study identified key risk factors for developing high cholesterol (hypercholesterolemia). For men, elevated total cholesterol, triglycerides, smoking, and hypertension were significant. For women, initial total cholesterol and age were the primary predictors.

Area of Science:

  • Cardiovascular Health
  • Epidemiology
  • Preventive Medicine

Background:

  • Hypercholesterolemia is a major risk factor for cardiovascular diseases.
  • Identifying early risk factors is crucial for preventive strategies.

Purpose of the Study:

  • To investigate the risk factors associated with the development of hypercholesterolemia.
  • To differentiate risk factors between males and females.

Main Methods:

  • Longitudinal study of 4,371 subjects (1976-1991) with regular medical checkups.
  • Serum total cholesterol levels monitored, with hypercholesterolemia defined as ≥250 mg/dl.
  • Cox's proportional hazards model used to analyze risk factors based on baseline and follow-up data.

Main Results:

  • In males, significant predictors included baseline total cholesterol, triglycerides, smoking, and the development of hypertension.
  • In females, baseline total cholesterol and age were identified as significant predictors.
  • Lifestyle factors and baseline health metrics influenced hypercholesterolemia onset differently by sex.

Conclusions:

  • Specific risk factors for hypercholesterolemia vary between men and women.
  • Early identification and management of factors like smoking, hypertension, and baseline cholesterol levels are vital for prevention.

More Related Videos

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction03:42

A Murine Model of Hyperlipidemia-Induced Heart Failure with Preserved Ejection Fraction

Published on: March 29, 2024

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...